Azithromycin and clarithromycin are newer macrolides that expand the spectrum of erythromycin. They are better tolerated and offer a more convenient dosage schedule but at greater cost to the patient. In addition to offering alternatives to traditional macrolide indications, they also hold promise for the therapy of less common pathogens, particularly in patients with AIDS.
机构:
UNIV CALIF SAN FRANCISCO, SCH PHARM, DIV CLIN PHARM, RM C-152, BOX 0622, SAN FRANCISCO, CA 94143 USAUNIV CALIF SAN FRANCISCO, SCH PHARM, DIV CLIN PHARM, RM C-152, BOX 0622, SAN FRANCISCO, CA 94143 USA
KANATANI, MS
GUGLIELMO, BJ
论文数: 0引用数: 0
h-index: 0
机构:
UNIV CALIF SAN FRANCISCO, SCH PHARM, DIV CLIN PHARM, RM C-152, BOX 0622, SAN FRANCISCO, CA 94143 USAUNIV CALIF SAN FRANCISCO, SCH PHARM, DIV CLIN PHARM, RM C-152, BOX 0622, SAN FRANCISCO, CA 94143 USA
GUGLIELMO, BJ
WESTERN JOURNAL OF MEDICINE,
1994,
160
(01):
: 31
-
37